We receive funding from a variety of sources that recognize the value of our high-impact research.
Molecular Mechanisms of Severe Diabetic Retinopathy. Joshua Jianxin Wang (Co-Investigator). NIH/NEI. $2,374,855. 2/1/2020-5/1/2029.
Molecular Mechanisms of Severe Diabetic Retinopathy. Sarah Zhang (Principal Investigator). National Eye Institute/NIH. $2,374,855. 9/1/2024-5/1/2029.
Regulatory mechanisms for retinal ganglion cell genesis. Xiuqian Mu (Principal Investigator). National Eye Institute. $2,311,139. 8/1/2023-4/1/2028.
Investigating the Action and Physiological Role of Slc4a11 in the Cornea. Sangita Patel (Co-Investigator). NIH National Eye Institute. $3,944,767. 2/1/2018-1/1/2028.
A Ribozyme Rescue Strategy for Dry Age-Related Macular Degeneration. John Sullivan (Principal Investigator). VA Central Office. $330,000. 1/1/2025-12/1/2027.
Injuries of the corneal endothelium. Sangita Patel (Principal Investigator). Department of Veterans Affairs, Biomedical Laboratory Research and Development. $543,160. 10/1/2023-9/1/2027.
“Injuries of the Corneal Endothelium”. Steven Fliesler (Co-Investigator). VA. $543,160. 10/1/2023-9/1/2027.
Optimizing Enhanced Hammerhead Ribozymes for Retinal Nucleic Acid Therapeutics. John Sullivan (Principal Investigator). NIH/NEI Scored 11% (Impact 28) on first submission. $2,239,262. 8/1/2023-3/1/2027.
Nuclear Encoded Humanin Isoforms and Mitochondria in Age-related Macular Degeneration. Sarah Zhang (Principal Investigator). National Eye Institute/NIH. $442,000. 2/1/2025-1/1/2027.
“Research Career Scientist Award (GS-15)”. Steven Fliesler (Principal Investigator). Dept of Veterans Affairs (VA). $637,073. 10/1/2021-9/1/2026.
ER stress and diabetic retinopathy. Sarah Zhang (Principal Investigator). National Eye Institute/NIH. $1,792,443. 9/1/2010-2/1/2026.
Development of Enhanced Hammerhead Ribozymes (E-hhRzs) as Therapeutics for AMD and other Retinal Diseases. John Sullivan (Principal Investigator). JB McDonald Foundation, Evergreen CO Donald R. McJunkin, President. $30,000. 1/1/2022-12/1/2025.
Epigenetic Architecture of the RPE and Choroid: Identification of Therapeutic Targets For AMD. Margaret DeAngelis (Principal Investigator). Macular Degeneration Foundation, Inc. $500,000. 5/1/2020-7/1/2025.
Characterizing Adult Strabismus in the National Veteran's Administration (VA) Health System. John Lillvis (Principal Investigator). Buffalo Translational Consortium. 7/1/2022-6/1/2025.
Regulation of mRNA decay in retinal development and maintenance. Xiuqian Mu (Principal Investigator). National Eye Institute. $2,024,085. 4/1/2020-2/1/2025.
ER stress and diabetic retinopathy. Joshua Jianxin Wang (Co-Investigator). NIH/NEI. 9/1/2010-2/1/2025.
Ancestry Network for the human cell atlas in the eye. Margaret DeAngelis (Co-Principal Investigator). Chan-Zuckerberg Initiative. $536,859. 2/1/2022-1/1/2025.
Pediatric network for the human cell atlas in the eye. Margaret DeAngelis (Co-Principal Investigator). Chan-Zuckerberg. $517,500. 2/1/2022-1/1/2025.
Deconstructing and modeling the single cell architecture of the age-related macular degeneration retina. Margaret DeAngelis (Co-Principal Investigator). NEI/NIH. $1,822,713. 1/1/1900-1/1/2025.
A Ribozyme Rescue Strategy for Dry Age-Related Macular Degeneration. John Sullivan (Principal Investigator). Veterans Administration BLRD Merit Award. $715,000. 10/1/2009-12/1/2024.
Recent Publications
Xing Z, Wu F, Cortes-Gomez E, Pao A, Gao L, Douglas A, Li Y, Spernyak JA, Wong GW, Singh PK, Wang J, Liu S, Thanavala Y, MacDonald IM, Mu X, Yu YE. (2025) Genetic Analysis of Choroideremia-Related Rab Escort Proteins. International journal of molecular sciences (Apr), 26(8)